LUNG Pulmonx Corp - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 4, 2026, Pulmonx Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 32,645,270 shares of the Company’s common stock were present or represented by proxy at the Annual Meeting, which represented approximately 77.29% of the Company’s 42,237,203 shares of common stock that were outstanding and entitled to vote at the meeting as of the record date of April 7, 2026. At the Annual Meeting, the stockholders of the Company considered the three proposals outlined below, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 22, 2026 (the “Proxy Statement”).

Proposal 1 – Election of Directors

The stockholders elected each of the three nominees for Class III director to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successor has been elected and qualified. The voting results were as follows:

For

Withheld

Broker Non-Votes

Thomas W. Burns

19,751,638

1,063,272

11,830,360

Georgia Garinois-Melenikiotou

17,680,826

3,134,084

11,830,360

Dana G. Mead, Jr.

19,853,196

961,714

11,830,360

Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm

The stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows:

For

Against

Abstain

31,458,698

97,509

1,089,063

There were no broker non-votes with respect to Proposal 2.

Proposal 3 – Non-Binding Advisory Vote to Approve the Company’s Executive Compensation

The stockholders approved, on a non-binding advisory basis, the Company’s executive compensation as disclosed in the Proxy Statement. The voting results were as follows:

For

Against

Abstain

Broker Non-Votes

17,196,362

3,485,784

132,764

11,830,360